Related Experiment Videos
[Antihypertensive drug-drug interactions]
Francisco J Morales-Olivas1, Luis Estañ
1Departamento de Farmacología, Universidad de Valencia, Valencia, España. morales@uv.es
Medicina Clinica
|June 2, 2005
Summary
Drug interactions can reduce antihypertensive treatment effectiveness, especially in elderly patients with multiple conditions. Understanding pharmacokinetic interactions, particularly with cytochrome P450 enzymes, is crucial for prevention.
Area of Science:
- Pharmacology
- Clinical Pharmacy
Context:
- Elderly hypertensive patients often have comorbidities requiring polypharmacy.
- Drug interactions can lead to antihypertensive treatment failure.
- The incidence of drug interactions increases with the number of drugs administered.
Purpose:
- To highlight the significance of drug interactions in antihypertensive therapy.
- To identify specific antihypertensive drug classes prone to interactions.
- To emphasize the role of pharmacokinetic mechanisms in drug interactions.
Summary:
- Drug interactions modify drug effects, impacting treatment efficacy, particularly in polypharmacy scenarios common in elderly hypertensive patients.
- While diuretics and ACE inhibitors are less involved, lipophilic beta-blockers and calcium channel blockers (non-dihydropyridine) exhibit clinically relevant interactions, often pharmacokinetic.
- Cytochrome P450 metabolism and P-glycoprotein transport are key mechanisms, with genetic polymorphisms contributing to inter-individual variability and interaction risks.
Impact:
- Increased awareness of drug interactions can improve antihypertensive treatment outcomes.
- Understanding interaction mechanisms aids in identifying and preventing adverse events.
- Recognition of pharmacokinetic interactions is vital for personalized medicine and patient safety.